New cancer clinical trial: Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer

Published on: March 30, 2018 at 12:00PM
Conditions:   Rectal Neoplasms;   Drug Therapy;   Radiation
Interventions:   Drug: FOLFOXIRI;   Radiation: Short-Course Radiation Therapy(5Gy*5);   Drug: XELOX
Sponsor:   China Medical University, China
Not yet recruiting
https://ift.tt/2EafE49